Senate Committee Restores FDA Funding For FY ’12
This article was originally published in The Tan Sheet
Executive Summary
The Senate Appropriations Committee gives FDA a boost for fiscal 2012 that likely will stick, thanks to the recent debt ceiling compromise.
You may also be interested in...
In Brief
Move Free, MegaRed extensions lift Schiff
House FDA Budget Bill Boosts User Fees, Trims Direct Appropriations
A House Appropriations subcommittee recommends cutting FDA's fiscal 2012 direct appropriations 11.5% while increasing user fees nearly 25%.
FDA Gets Boost In Fiscal 2011 Compromise, Cuts Loom For 2012
FDA is spared from the worst spending cuts for the remainder of fiscal 2011, but congressional Democrats warn of the potential for deep cuts ahead.